Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia

Chromosomal rearrangements of the mixed lineage leukemia (MLL) gene occur in ∼10% of B-cell acute lymphoblastic leukemia (B-ALL) and define a group of patients with dismal outcomes. Immunohistochemical staining of bone marrow biopsies from most of these patients revealed aberrant expression of BCL6,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtz, Christian, Chan, Lai N., Geng, Huimin, Ballabio, Erica, Xiao, Gang, Deb, Gauri, Khoury, Haytham, Chen, Chun-Wei, Armstrong, Scott A., Chen, Jianjun, Ernst, Patricia, Melnick, Ari, Milne, Thomas, Müschen, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719625/
https://www.ncbi.nlm.nih.gov/pubmed/31395741
http://dx.doi.org/10.1101/gad.327593.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719625/
https://www.ncbi.nlm.nih.gov/pubmed/31395741
http://dx.doi.org/10.1101/gad.327593.119

Ejemplares similares